Ram Shankar Upadhayaya

Renowned for securing substantial funds and investments, he has led multidisciplinary teams to global success, bridging academia and industry seamlessly. A trailblazer in new drug discovery, with expertise in oncology, autoimmune, metabolic disorders, and infectious diseases, boast a portfolio comprising 25 peer-reviewed scientific publications and 14 patent applications.

A profound understanding of cutting-edge drug discovery technologies, including Medicinal chemistry, proteomics, genomics, and machine learning made him a true contributor in translational science. A master collaborator, initiated and managed thriving global businesses, prioritizing sustainable growth through meticulous contractual agreements and high-quality product delivery. As a visionary planner, navigate the complex intersection of science and finance, adapting to market dynamics while maintaining a holistic perspective on objectives. With exceptional communication and motivational skills, drive success in fiercely competitive markets, exemplifying executive leadership in the life science industry.

Dr. Ram has worked in renowned industries and academic institutions, including Harvard Medical School, nxt2b-Biomics AB, Sweden, TRN – The Research Network UK, Uppsala University, Sweden, the Institute of Molecular Medicine, the Max Planck Institute in Germany, and the MRC in London.